RenovoRx Stock (NASDAQ: RNXT) stock price, news, charts, stock research, profile.
Open | $1.230 |
Close | - |
Volume / Avg. | 9.491K / 48.805K |
Day Range | 1.220 - 1.250 |
52 Wk Range | 0.531 - 3.290 |
Market Cap | $26.924M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.07% |
Days to Cover | 1.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of RenovoRx (NASDAQ: RNXT) through any online brokerage.
Other companies in RenovoRx’s space includes: Serina Therapeutics (AMEX:SER), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Palatin Techs (AMEX:PTN) and Sensei Biotherapeutics (NASDAQ:SNSE).
The latest price target for RenovoRx (NASDAQ: RNXT) was reported by Alliance Global Partners on Friday, February 2, 2024. The analyst firm set a price target for 4.00 expecting RNXT to rise to within 12 months (a possible 220.03% upside). 3 analyst firms have reported ratings in the last year.
The stock price for RenovoRx (NASDAQ: RNXT) is $1.2499 last updated Today at April 19, 2024 at 10:43 AM EDT.
There are no upcoming dividends for RenovoRx.
RenovoRx’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for RenovoRx.
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.